Rankings
▼
Calendar
AUPH Q3 2025 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$73M
+8.4% YoY
Gross Profit
$65M
88.4% margin
Operating Income
$30M
40.5% margin
Net Income
$32M
42.9% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
+4.9%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$44M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$528M
Total Liabilities
$162M
Stockholders' Equity
$366M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$73M
$68M
+8.4%
Gross Profit
$65M
$62M
+5.2%
Operating Income
$30M
$12M
+153.2%
Net Income
$32M
$14M
+119.9%
Revenue Segments
Product
$71M
96%
License, Collaboration and Royalty Revenue
$3M
4%
← FY 2025
All Quarters
Q4 2025 →